Dec 2017 $12 M No. 7 $10 to $50 million 20
Endostim, Inc.: Raise no. 7, Dec 2017 × Investors in this round 20 investors had bought by the notice of Jan 16, 2018: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $12 M of $25 M offered; $13 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kimberly D. Pinson · Executive Officer Paul K. Goode · Executive Officer Rohan J. Hoare · Executive Officer, Director Virender K. Sharma · Executive Officer Alexander D. Schmitz · Director Douglas D. French · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kimberly Pinson, Chief Financial Officer and Assistant Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jan 16, 2018. Read the notice at the SEC .
equity, options SEC Mar 2016 $11 M No. 6 $10 to $50 million 83
Endostim, Inc.: Raise no. 6, Mar 2016 × Investors in this round 83 investors had bought by the notice of Mar 23, 2016: 83 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $20 M offered; $9 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bevil J. Hogg · Executive Officer, Director Paul S. Goode · Executive Officer Peggy S. Stohr · Executive Officer Shai S. Policker · Executive Officer Alexander S. Schmitz · Director Douglas D. French · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 23, 2016. Read the notice at the SEC .
equity, options SEC May 2015 $3 M No. 5 $2 to $10 million 1
Endostim, Inc.: Raise no. 5, May 2015 × Investors in this round 1 investor had bought by the notice of May 8, 2015: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $5 M offered; $3 M still to sell
Smallest investment taken $2,500,003
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bevil J. Hogg · Executive Officer, Director Paul G. Goode · Executive Officer Peggy S. Stohr · Executive Officer Shai G. Policker · Executive Officer Douglas D. French · Director Fred C. Goad · Director Jeffrey M. McDonnell · Director Ralph G. Dacey · Director Raul E. Perez · Director Virender K. Sharma · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D, newest notice filed May 8, 2015. Read the notice at the SEC .
equity SEC Jun 2014 $6 M No. 4 $2 to $10 million 72
Endostim, Inc.: Raise no. 4, Jun 2014 × Investors in this round 72 investors had bought by the notice of Jul 10, 2014: 72 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $8 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $100,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bevil J. Hogg · Executive Officer, Director Paul G. Goode · Executive Officer Peggy S. Stohr · Executive Officer Shai G. Policker · Executive Officer Douglas D. French · Director Fred C. Goad · Director Jeffrey M. McDonnell · Director Ralph G. Dacey · Director Raul E. Perez · Director Virender K. Sharma · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Stifel, Nicolaus & Company, Incorporated (CRD 793) · St. Louis, Missouri Sold in AZ, CA, CO, CT, DC, FL, IL, KY, LA, MO, NY, SC, TN Healthios Capital Markets, LLC (CRD 115542) · Northbrook, Illinois Sold in AZ, CA, CO, CT, DC, FL, IL, KY, LA, MO, NY, SC, TN Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 10, 2014. Read the notice at the SEC .
debt, options SEC Dec 2012 $14 M No. 3 $10 to $50 million 81
Endostim, Inc.: Raise no. 3, Dec 2012 × Investors in this round 81 investors had bought by the notice of May 29, 2013: 81 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $17 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $544,407
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bevil J. Hogg · Executive Officer, Director Peggy S. Stohr · Executive Officer Douglas D. French · Director Fred C. Goad · Director Jeffrey M. McDonnell · Director Ralph G. Dacey · Director Raul E. Perez · Director Virender K. Sharma · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Stifel, Nicolaus & Company, Incorporated (CRD 793) · St. Louis, Missouri Sold in AZ, CA, CO, CT, DC, FL, IL, KY, LA, MA, MO, SC, TN, TX Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D and 4 amendments, newest notice filed May 29, 2013. Read the notice at the SEC .
equity SEC Nov 2011 $6 M No. 2 $2 to $10 million 10
Endostim, Inc.: Raise no. 2, Nov 2011 × Investors in this round 10 investors had bought by the notice of Dec 5, 2011: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bevil J. Hogg · Executive Officer, Director Peggy G. Stohr · Executive Officer Doug K. French · Director Fred K. Goad · Director Jeffrey K. McDonnell · Director Ralph G. Dacey · Director Raul E. Perez · Director Virender K. Sharma · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Peggy S. Stohr, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 5, 2011. Read the notice at the SEC .
equity SEC Jul 2010 $6 M No. 1 $2 to $10 million 26
Endostim, Inc.: Raise no. 1, Jul 2010 × Investors in this round 26 investors had bought by the notice of Jul 30, 2010: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bevil J. Hogg · Executive Officer, Director Doug E. French · Director Fred E. Goad · Director Jeffrey E. McDonnell · Director Raul E. Perez · Director Sarah E. Sharma · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Raul E. Perez, Chairman of the Board of Directors. Source: SEC Form D, newest notice filed Jul 30, 2010. Read the notice at the SEC .
equity SEC